<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
		<id>http://muscle.biouml.org/index.php?action=history&amp;feed=atom&amp;title=MEOX1</id>
		<title>MEOX1 - Revision history</title>
		<link rel="self" type="application/atom+xml" href="http://muscle.biouml.org/index.php?action=history&amp;feed=atom&amp;title=MEOX1"/>
		<link rel="alternate" type="text/html" href="http://muscle.biouml.org/index.php?title=MEOX1&amp;action=history"/>
		<updated>2026-05-16T07:07:59Z</updated>
		<subtitle>Revision history for this page on the wiki</subtitle>
		<generator>MediaWiki 1.29.2</generator>

	<entry>
		<id>http://muscle.biouml.org/index.php?title=MEOX1&amp;diff=14&amp;oldid=prev</id>
		<title>Fedor at 07:35, 26 January 2018</title>
		<link rel="alternate" type="text/html" href="http://muscle.biouml.org/index.php?title=MEOX1&amp;diff=14&amp;oldid=prev"/>
				<updated>2018-01-26T07:35:01Z</updated>
		
		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class='diff-marker' /&gt;
				&lt;col class='diff-content' /&gt;
				&lt;col class='diff-marker' /&gt;
				&lt;col class='diff-content' /&gt;
				&lt;tr style='vertical-align: top;' lang='en'&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black; text-align: center;&quot;&gt;Revision as of 07:35, 26 January 2018&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l60&quot; &gt;Line 60:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 60:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;HOXA10(-0.76), CLCN1(-0.71), KIF1C(-0.70), ZNF865(-0.68), RYR1(-0.67), ZC2HC1C(-0.67), NR1H2(-0.66), ...&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;HOXA10(-0.76), CLCN1(-0.71), KIF1C(-0.70), ZNF865(-0.68), RYR1(-0.67), ZC2HC1C(-0.67), NR1H2(-0.66), ...&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;[[Category:muscle_DEGs]]&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;!-- diff cache key my_wiki:diff:version:1.11a:oldid:6:newid:14 --&gt;
&lt;/table&gt;</summary>
		<author><name>Fedor</name></author>	</entry>

	<entry>
		<id>http://muscle.biouml.org/index.php?title=MEOX1&amp;diff=6&amp;oldid=prev</id>
		<title>Fedor: Created page with &quot;Mesodermal transcription factor that plays a key role in somitogenesis and is specifically required for sclerotome development.   Required for maintenance of the sclerotome po...&quot;</title>
		<link rel="alternate" type="text/html" href="http://muscle.biouml.org/index.php?title=MEOX1&amp;diff=6&amp;oldid=prev"/>
				<updated>2018-01-24T17:01:22Z</updated>
		
		<summary type="html">&lt;p&gt;Created page with &amp;quot;Mesodermal transcription factor that plays a key role in somitogenesis and is specifically required for sclerotome development.   Required for maintenance of the sclerotome po...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Mesodermal transcription factor that plays a key role in somitogenesis and is specifically required for sclerotome development. &lt;br /&gt;
&lt;br /&gt;
Required for maintenance of the sclerotome polarity and formation of the cranio-cervical joints (PubMed:23290072, PubMed:24073994). &lt;br /&gt;
&lt;br /&gt;
&amp;lt;cite&amp;gt;1&amp;lt;/cite&amp;gt; - The formation of skeletal muscle: from somite to limb&lt;br /&gt;
&lt;br /&gt;
====Action====&lt;br /&gt;
http://www.uniprot.org/uniprot/P50221#function&lt;br /&gt;
&lt;br /&gt;
Binds specifically to the promoter of target genes and regulates their expression. &lt;br /&gt;
&lt;br /&gt;
Activates expression of NKX3-2 in the sclerotome. &lt;br /&gt;
&lt;br /&gt;
Activates expression of CDKN1A and CDKN2A in endothelial cells, acting as a regulator of vascular cell proliferation. &lt;br /&gt;
&lt;br /&gt;
While it activates CDKN1A in a DNA-dependent manner, it activates CDKN2A in a DNA-independent manner. &lt;br /&gt;
&lt;br /&gt;
Required for hematopoietic stem cell (HSCs) induction via its role in somitogenesis: &lt;br /&gt;
specification of HSCs occurs via the deployment of a specific endothelial precursor population, which arises within a sub-compartment of the somite named endotome.&lt;br /&gt;
&lt;br /&gt;
Analysis of pre-myogenic factors showed that expression of PAX3, MEOX1 and EYA2 was significantly increased by MYOD &amp;lt;cite&amp;gt;2&amp;lt;/cite&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Meox1 promotes vascular smooth muscle cells (SMCs) phenotypic modulation and injury-induced vascular remodeling by regulating the FAK-ERK1/2-autophagy signaling cascade&amp;lt;cite&amp;gt;3&amp;lt;/cite&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Meox1 initiates G2 cell-cycle arrest within muscle stem cells&amp;lt;cite&amp;gt;4&amp;lt;/cite&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Pax3 is both necessary and sufficient to induce skeletal myogenesis, Meox1 is required for Pax3 expression and subsequent myogenic differentiation ([21–23] in &amp;lt;cite&amp;gt;5&amp;lt;/cite&amp;gt;).&lt;br /&gt;
&lt;br /&gt;
Transduction of hAFS (human amniotic fluid stem) cells with MYOD lentiviruses induces skeletal myogenic differentiation in vitro and morphological and functional regeneration of injured muscle in vivo.&lt;br /&gt;
Analysis of pre-myogenic factors showed that expression of PAX3, MEOX1 and EYA2 was significantly increased by MYOD &amp;lt;cite&amp;gt;6&amp;lt;/cite&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
====Pathways====&lt;br /&gt;
ERK1/2 for vascular smooth muscle cells (SMCs) &amp;lt;cite&amp;gt;3&amp;lt;/cite&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====Diseases====&lt;br /&gt;
Diseases associated with MEOX1 include Klippel-Feil Syndrome 2 and Isolated Klippel-Feil Syndrome. &lt;br /&gt;
&lt;br /&gt;
====References====&lt;br /&gt;
&amp;lt;biblio&amp;gt;&lt;br /&gt;
#1 pmid=12587921&lt;br /&gt;
#2 pmid=24331373&lt;br /&gt;
#3 pmid=29113690&lt;br /&gt;
#4 pmid=28686860&lt;br /&gt;
#5 pmid=28469839&lt;br /&gt;
#6 pmid=24331373 &lt;br /&gt;
&amp;lt;/biblio&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Expression====&lt;br /&gt;
Upregulated - mainly after 1 hour after exercise and has increased level after long training.&lt;br /&gt;
&lt;br /&gt;
[[File:MEOX1.png|MEOX1 expression]]&lt;br /&gt;
&lt;br /&gt;
====Coregulation====&lt;br /&gt;
VASP (0.89), CDC42EP1 (0.88), IQCJ-SCHIP1 (0.87), TES(0.87), ABRACL(0.87), KCNK6(0.87), TINAGL1(0.87), GLIS2(0.86), PCGF2(0.86), IL27RA(0.86), VWA1(0.86), PLEKHG2(0.85), PDGFB(0.85), &lt;br /&gt;
ENG(0.85), ERF(0.85), SHROOM1(0.84), FAM57A(0.84), ELFN1(0.84), PPP1R13L(0.84), ITGA5(0.84), RAB32(0.84), MYADM(0.84), RNF152(0.83), CNN2(0.83), CDR2L(0.83), TMC6(0.83),&lt;br /&gt;
ZBTB46(0.83), NOVA2(0.87), TGFB1I1(0.83), ELF4(0.83), PGM2(0.83), GBP1(0.83), PRKD2(0.83), NOL4L(0.82), SH2D3C(0.82), ZYX(0.82), TPM4(0.82), EPHA2(0.82), NECTIN2(0.82),&lt;br /&gt;
SERPINH1(0.82), ACTN4(0.82), MMRN2(0.81), TAL1(0.82), SPATA2L(0.81), TRIM47(0.81), TGFB1(0.81), MYH9(0.81), LCP2(0.81), YWHAH(0.81), BCL6B(0.81), DLL1(0.80),&lt;br /&gt;
TAGLN2(0.80), TBC1D9(0.80), SOX18(0.80), ID2(0.80), TAGLN2P1(0.80), MARCKSL1(0.80), MYL6P5(0.80), DLC1(0.79), ACTG1(0.79), HEYL(0.79), KCTD15(0.79), ...&lt;br /&gt;
&lt;br /&gt;
HOXA10(-0.76), CLCN1(-0.71), KIF1C(-0.70), ZNF865(-0.68), RYR1(-0.67), ZC2HC1C(-0.67), NR1H2(-0.66), ...&lt;/div&gt;</summary>
		<author><name>Fedor</name></author>	</entry>

	</feed>